The latest closing stock price for Cadrenal Therapeutics as of June 06, 2025 is 15.10.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $-756 today, roughly -1 times their original investment - a -50.57% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 61.80 on January 20, 2023.
The Cadrenal Therapeutics 52-week high stock price is 22.90, which is 51.7% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 5.70, which is 62.3% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 13.53.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $-756 today, roughly -1 times their original investment - a -50.57% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 61.80 on January 20, 2023.
The Cadrenal Therapeutics 52-week high stock price is 22.90, which is 51.7% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 5.70, which is 62.3% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 13.53.